Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics DataJill M. Pulley, David M. Aronoff, Jillian P. Rhoads et al.|The Annual Review of Pharmacology and Toxicology|2019Cited by 59
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor–Biased Ligand in Adults With COVID-19Wesley H. Self, Peter K. Henke, Ivor S. Douglas et al.|JAMA|2023Cited by 56
Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association StudyThomas A. Werfel, Rebecca S. Cook, Donna J. Hicks et al.|Molecular Cancer Therapeutics|2020Cited by 23
Data from Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association StudyThomas A. Werfel, Rebecca S. Cook, Donna J. Hicks et al.|Unknown|2023Cited by 0
Figure S2 from Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association StudyThomas A. Werfel, Rebecca S. Cook, Bushra Rahman et al.|Unknown|2023Cited by 0